In a recent development, the German drug company, Boehringer Ingelheim,
has agreed to pay $650 million to settle the thousands of lawsuits against
it for the blood thinner, Pradaxa.
Pradaxa functions as a blood thinner, but the lawsuits claim that its power
could be overwhelming at times, sometimes causing fatal bleeding. Emergency
workers even claimed that the bleeding didn’t respond to typical
treatments for life-threatening bleeding.
The $650 million settlement is likely to resolve the majority of the 4,000
cases filed by patients and families claiming that Boehringer didn’t
provide strong enough warnings about Pradaxa’s effects.
Pradaxa is prescribed as a means to prevent blood clots and Boehringer
Ingelheim still claims that the drug has proven effective since it was
approved in 2010. The drug was created as a means to replace a different
blood thinner that required patients to have frequent drug tests and maintain
a very strict diet.
While the settlement is being paid out, Pradaxa still remains on the market
and an antidote for excessive bleeding cases is being developed.
If you or your family members have experienced negative effects or even
death as a result of Pradaxa or any other drug, please
contact Golomb & Honik for help with your case. Our experienced team of attorneys help clients
in the Philadelphia, Pennsylvania area, New Jersey, and nationwide. Call
us at (855) 889-5389.